![CollabRx, Inc. Logo](/news-release/logo/240848/0/240848.jpg?lastModified=12%2F09%2F2016%2023%3A44%3A10&size=2)
CollabRx Featured on NBC News (VIDEO)
06 août 2013 06h02 HE
|
CollabRx, Inc.
SAN FRANCISCO, Aug. 6, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, was featured on an NBC Bay...
![CollabRx, Inc. Logo](/news-release/logo/240848/0/240848.jpg?lastModified=12%2F09%2F2016%2023%3A44%3A10&size=2)
CollabRx Featured in Forbes Article: "Can We Build A Kickstarter For Cancer?"
05 août 2013 09h02 HE
|
CollabRx, Inc.
SAN FRANCISCO, Aug. 5, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, was featured a Forbes...
CollabRx, Inc. Schedules First Quarter Fiscal Year 2014 Financial Conference Call and Business Update
31 juil. 2013 09h05 HE
|
CollabRx, Inc.
SAN FRANCISCO, July 31, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on August 13,...
![CollabRx, Inc. Logo](/news-release/logo/240848/0/240848.jpg?lastModified=12%2F09%2F2016%2023%3A44%3A10&size=2)
CollabRx to Present at the 2013 Southern California Investor Conference
30 juil. 2013 09h02 HE
|
CollabRx, Inc.
SAN FRANCISCO, July 30, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announces that Thomas R....
![CollabRx, Inc. Logo](/news-release/logo/240848/0/240848.jpg?lastModified=12%2F09%2F2016%2023%3A44%3A10&size=2)
CollabRx Retains Hayden IR to Develop Strategic Investor Relations Program
25 juil. 2013 16h02 HE
|
CollabRx, Inc.
SAN FRANCISCO, July 25, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announced it has engaged...
![CollabRx, Inc. Logo](/news-release/logo/240848/0/240848.jpg?lastModified=12%2F09%2F2016%2023%3A44%3A10&size=2)
CollabRx to Collaborate With the University of Chicago Medical Center on Clinical Cancer Sequencing and Interpretation
18 juin 2013 09h21 HE
|
CollabRx, Inc.
SAN FRANCISCO, June 18, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced a...
![CollabRx, Inc. Logo](/news-release/logo/240848/0/240848.jpg?lastModified=12%2F09%2F2016%2023%3A44%3A10&size=2)
CollabRx Reports Fourth Quarter and Fiscal Year 2013 Financial Results
03 juin 2013 16h00 HE
|
CollabRx, Inc.
SAN FRANCISCO, Calif., June 3, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (the "Company") (Nasdaq:CLRX) today announced financial results for the fourth quarter and for the full Fiscal Year 2013, which...
![CollabRx, Inc. Logo](/news-release/logo/240848/0/240848.jpg?lastModified=12%2F09%2F2016%2023%3A44%3A10&size=2)
CollabRx Schedules Q4 and Full Fiscal Year 2013 Financial Conference Call and Business Update
21 mai 2013 15h32 HE
|
CollabRx, Inc.
SAN FRANCISCO, May 21, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on June 3,...
![CollabRx, Inc. Logo](/news-release/logo/240848/0/240848.jpg?lastModified=12%2F09%2F2016%2023%3A44%3A10&size=2)
CollabRx and GeneInsight to Collaborate on Interpretation and Reporting Service for Clinical Genetic Sequencing
08 mai 2013 09h01 HE
|
CollabRx, Inc.
SAN FRANCISCO and BOSTON, May 8, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing the clinical interpretation of molecular diagnostic testing, and...
![CollabRx, Inc. Logo](/news-release/logo/240848/0/240848.jpg?lastModified=12%2F09%2F2016%2023%3A44%3A10&size=2)
CollabRx Partners With Sengenics for Molecular Diagnostics
09 avr. 2013 07h01 HE
|
CollabRx, Inc.
SAN FRANCISCO, April 9, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), today announced a partnership with Sengenics, a leading genetic diagnostics company, to provide turn-key diagnostic...